☆ 4.6 Letter

The Selective Use of Combination Therapy in Patients with Inflammatory Bowel Disease Resistant to Anti-TNF: to Whom, How and How Long?

JOURNAL OF CROHNS & COLITIS (2016)

Journal

JOURNAL OF CROHNS & COLITIS

Volume 10, Issue 12, Pages 1451-1451

Publisher

OXFORD UNIV PRESS

DOI: 10.1093/ecco-jcc/jjw089

Keywords

Anti-TNF; immunomodulator; combination therapy; Crohn's disease

Categories

Gastroenterology & Hepatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.